Thealternative C3 complement system, as a key inflammatory mediator, seems to beinvolved in the atherosclerotic process, studies have reported an increase in theexpression of complement cascade components, including C3-derived products, inFamilial hypercholesterolemia patients who show no clinical signs of coronaryartery disease [24]. This evidence concerns the gene C3 and Hypercholesterolemia.